Andrea Eisen Selected Research

Ovariectomy (Oophorectomy)

1/2022	Bilateral Oophorectomy and the Risk of Breast Cancer in BRCA1 Mutation Carriers: A Reappraisal.
6/2021	Breast cancer risk after age 60 among BRCA1 and BRCA2 mutation carriers.
10/2020	Cognitive markers of dementia risk in middle-aged women with bilateral salpingo-oophorectomy prior to menopause.
6/2019	Oophorectomy and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers.
1/2018	Age-specific ovarian cancer risks among women with a BRCA1 or BRCA2 mutation.
1/2018	Hormone Replacement Therapy After Oophorectomy and Breast Cancer Risk Among BRCA1 Mutation Carriers.
1/2017	Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers.
9/2015	Risk factors for endometrial cancer among women with a BRCA1 or BRCA2 mutation: a case control study.
6/2015	Effect of Oophorectomy on Survival After Breast Cancer in BRCA1 and BRCA2 Mutation Carriers.
5/2014	Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrea Eisen Research Topics

Disease

56	Breast Neoplasms (Breast Cancer) 02/2022 - 08/2002
21	Neoplasms (Cancer) 01/2022 - 06/2004
8	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 01/2005
3	Unilateral Breast Neoplasms 03/2022 - 10/2019
2	Fallopian Tube Neoplasms 01/2022 - 01/2018
2	Diarrhea 10/2018 - 09/2009
2	Fatigue 03/2016 - 09/2009
2	Carcinoma (Carcinomatosis) 01/2016 - 07/2013
1	Dementia (Dementias) 10/2020
1	Pain (Aches) 12/2017
1	Carcinogenesis 09/2016
1	Neoplasm Micrometastasis 04/2016
1	Sleep Deprivation 03/2016
1	Endometrial Neoplasms (Endometrial Cancer) 09/2015
1	Neutropenia 07/2012
1	Anemia 07/2012
1	Nausea 07/2012
1	Pneumonia (Pneumonitis) 09/2009
1	Exanthema (Rash) 09/2009
1	Stomatitis 09/2009
1	Cough 09/2009
1	Anorexia 09/2009

Drug/Important Bio-Agent (IBA)

10	Tamoxifen FDA LinkGeneric 09/2015 - 08/2002
6	Hormones (Hormone)IBA 01/2022 - 01/2007
4	Oral ContraceptivesIBA 01/2022 - 10/2005
4	Estrogen ReceptorsIBA 01/2022 - 07/2012
4	human ERBB2 proteinIBA 01/2022 - 07/2012
4	Trastuzumab (Herceptin)FDA Link 01/2021 - 03/2016
4	Biological ProductsIBA 09/2016 - 04/2005
3	Pharmaceutical PreparationsIBA 08/2020 - 01/2009
3	Progesterone FDA LinkGeneric 01/2018 - 10/2008
3	Raloxifene Hydrochloride (Evista)FDA Link 08/2007 - 08/2002
2	pertuzumabIBA 05/2020 - 10/2018
2	taxaneIBA 10/2018 - 07/2015
2	Estrogens (Estrogen)FDA Link 01/2018 - 10/2008
2	Biomarkers (Surrogate Marker)IBA 09/2016 - 03/2016
2	PlatinumIBA 01/2016 - 07/2013
2	Docetaxel (Taxotere)FDA Link 01/2016 - 07/2015
2	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2015 - 01/2009
2	exemestane (Aromasin)FDA Link 04/2008 - 04/2008
2	Aromatase InhibitorsIBA 04/2008 - 08/2002
2	ORALIT (ORS)IBA 01/2006 - 10/2005
1	Denosumab FDA Link 01/2022
1	hydroxide ionIBA 01/2022
1	Zoledronic Acid (Zometa)FDA Link 01/2022
1	Ibandronic Acid (Boniva)FDA Link 01/2022
1	Contraceptive Agents (Contraceptives)IBA 01/2022
1	Clodronic Acid (Clodronate)IBA 01/2022
1	Diphosphonates (Bisphosphonates)IBA 01/2022
1	Epidermal Growth Factor (EGF)IBA 01/2022
1	Ado-Trastuzumab EmtansineIBA 01/2021
1	Maytansine (Maitansine)IBA 05/2020
1	beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA 05/2020
1	AnthracyclinesIBA 10/2018
1	neratinibIBA 10/2018
1	Capecitabine (Xeloda)FDA Link 10/2018
1	Indicators and Reagents (Reagents)IBA 01/2018
1	RANK LigandIBA 01/2018
1	Analgesics (Analgesic Drugs)IBA 12/2017
1	4-hydroxybenzylcyanideIBA 10/2017
1	VitaminsIBA 09/2016
1	NucleotidesIBA 09/2016
1	PyridoxalIBA 09/2016
1	Vitamin B 6IBA 09/2016
1	Folic Acid (Vitamin M)FDA LinkGeneric 09/2016
1	Vitamin B Complex (B Vitamins)IBA 09/2016
1	ErbB Receptors (EGF Receptor)IBA 04/2016
1	MelatoninIBA 03/2016
1	IcrucumabIBA 01/2016
1	RamucirumabIBA 01/2016
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 01/2016
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2016
1	Epirubicin (Ellence)FDA LinkGeneric 07/2015
1	Paclitaxel (Taxol)FDA LinkGeneric 07/2015
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2015
1	Fluorouracil (Carac)FDA LinkGeneric 07/2015
1	P-2 (P 2)IBA 07/2015
1	DNA (Deoxyribonucleic Acid)IBA 10/2014
1	130-nm albumin-bound paclitaxelIBA 07/2013
1	Albumin-Bound Paclitaxel FDA Link 07/2013
1	AlbuminsIBA 07/2013
1	Cisplatin (Platino)FDA LinkGeneric 07/2012
1	Progesterone Receptors (Progesterone Receptor)IBA 07/2012
1	Sorafenib (BAY 43-9006)FDA Link 10/2011

Therapy/Procedure

21	Ovariectomy (Oophorectomy) 01/2022 - 06/2004
15	Therapeutics 01/2022 - 01/2005
11	Drug Therapy (Chemotherapy) 01/2021 - 01/2005
8	Adjuvant Chemotherapy 01/2022 - 07/2012
8	Mastectomy (Mammectomy) 06/2021 - 06/2004
6	Neoadjuvant Therapy 02/2022 - 06/2019
5	Prophylactic Mastectomy 03/2022 - 01/2007
5	Hormone Replacement Therapy (Therapy, Hormone Replacement) 06/2021 - 08/2002
5	Salpingo-oophorectomy 10/2020 - 01/2007
4	Radiotherapy 07/2014 - 01/2005
3	Chemoprevention 08/2007 - 08/2002
1	Contraception (Birth Control) 01/2022
1	Intrauterine Devices (Intrauterine Device) 01/2022
1	Aftercare (After-Treatment) 02/2021
1	Combination Drug Therapy (Combination Chemotherapy) 10/2018
1	Hysterectomy 09/2015